Platelet-derived microparticles and coagulation activation in breast cancer patients

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Thrombosis and Haemostasis

• Publication date

  2008-09-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1160/TH07-10-0602PMID 18841290
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating microparticles in breast cancer patients: a comparative analysis with established biomarkers.

  2008cited by this paper
• Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow.

  2008cited by this paper
• Microvesicle‐associated tissue factor and Trousseau's syndrome

  2007cited by this paper
• Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?

  2007cited by this paper
• Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress.

  2006cited by this paper
• Endothelial Cell–Derived Microparticles in Allogeneic Hematopoietic Stem Cell Recipients

  2006cited by this paper
• P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction.

  2006cited by this paper
• Tissue factor-positive microparticles in blood associated with coagulopathy in cancer

  2006cited by this paper
• Tissue factor-positive microparticles: Cellular origin and association with coagulation activation in patients with colorectal cancer

  2006cited by this paper
• Thrombosis and cancer: the role of screening for occult cancer and recognizing the underlying biological mechanisms.

  2006cited by this paper
• Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation.

  2005cited by this paper
• Prevalence, causes, and impact of cancer-associated thrombosis.

  2005cited by this paper
• The MET oncogene drives a genetic programme linking cancer to haemostasis

  2005cited by this paper
• Plasma Coagulation Markers in Patients with Solid Tumors and Venous Thromboembolic Disease Receiving Oral Anticoagulation Therapy

  2004cited by this paper
• Leukaemia/lymphoma cell microparticles in childhood mature B cell neoplasms

  2004cited by this paper
• Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation.

  2004cited by this paper
• Human cell‐derived microparticles promote thrombus formation in vivo in a tissue factor‐dependent manner

  2003cited by this paper
• Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin

  2003cited by this paper
• Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor.

  2003cited by this paper
• Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer.

  2003cited by this paper
• Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism.

  2002cited by this paper
• Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes.

  2002cited by this paper
• Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer

  2002cited by this paper
• High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer.

  2001cited by this paper
• Cell-derived Microparticles Circulate in Healthy Humans and Support Low Grade Thrombin Generation

  2001cited by this paper
• Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor

  2001cited by this paper
• Cellular origin and procoagulant properties of microparticles in meningococcal sepsis.

  2000cited by this paper
• HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Contribution of Distinct Adhesive Interactions to Platelet Aggregation in Flowing Blood

  1999cited by this paper
• Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant.

  1997cited by this paper
• Pre- and Postoperative State of Coagulation and Fibrinolysis in Plasma of Patients with Benign and Malignant Colorectal Disease - A Preliminary Study

  1996cited by this paper
• In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function.

  1996influential reference
• Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide.

  1994cited by this paper
• Immunohistochemical identification of tissue factor in solid tumors

  1992cited by this paper

• Platelet-derived extracellular vesicles expressing phosphatidyl serine associate with benign and malignant neoplasia and regional metastasis in dogs: a study of 113 dogs.

  2026cites this paper
• Cancer-Associated Arterial Thrombosis: Mechanisms and Risk Factors

  2026cites this paper
• Platelet Extracellular Vesicles as Natural Delivery Vehicles for Mitochondrial Dysfunction Therapy?

  2025cites this paper
• Platelet activation in breast cancer: mechanisms and therapeutic opportunities – a narrative review

  2025cites this paper
• Extracellular Vesicles Profile and Risk of Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma

  2025cites this paper
• Mitochondria transfer by platelet-derived microparticles regulates breast cancer bioenergetic states and malignant features.

  2023cites this paper
• Shedding Light on the Cell Biology of Platelet-Derived Extracellular Vesicles and Their Biomedical Applications

  2023cites this paper
• Tumor-educated platelets.

  2023cites this paper
• The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V

  2022cites this paper
• Methods to evaluate vascular function: a crucial approach towards predictive, preventive, and personalised medicine

  2022cites this paper
• Platelet Activation and Platelet Indices as Markers for Disease Progression in Women with Breast Cancer

  2022influential citation
• Pathophysiology of Coagulation and Emerging Roles for Extracellular Vesicles in Coagulation Cascades and Disorders

  2022cites this paper
• Phosphatidylserine-exposing tumor-derived microparticles exacerbate coagulation and cancer cell transendothelial migration in triple-negative breast cancer

  2021cites this paper
• A Hypercoagulable Hematological Metastasis Breast Cancer Model

  2021cites this paper
• Pancreatic Cancer and Platelets Crosstalk: A Potential Biomarker and Target

  2021cites this paper
• Platelet hyperactivation in multiple myeloma is also evident in patients with premalignant monoclonal gammopathy of undetermined significance

  2020cites this paper
• MICROPARTICLES IN HEMOPHILIA – FRIEND OR FOE? – TO IMPROVE HEMOSTASIS OR TO INDUCE ATHEROTHROMBOSIS?

  2020cites this paper
• Cellular Dust as a Novel Hope for Regenerative Cancer Medicine.

  2020cites this paper
• Platelet Microparticle Controversial Role in Cancer

  2020cites this paper
• Cell Biology and Translational Medicine, Volume 9: Stem Cell-Based Therapeutic Approaches in Disease

  2020influential citation
• Novel Aspects of Extracellular Vesicles as Mediators of Cancer-Associated Thrombosis

  2019cites this paper
• Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models

  2019cites this paper
• Role of Tissue Factor in Tumor Progression and Cancer-Associated Thrombosis

  2019cites this paper
• Increased Phosphatidylserine on Blood Cells in Oral Squamous Cell Carcinoma

  2019cites this paper
• Platelet-Derived Extracellular Vesicles

  2019cites this paper
• Snakebites and microvesicles: Popping bubbles

  2019cites this paper
• Thrombin Generation and Cancer: Contributors and Consequences

  2019cites this paper
• Acute Coronary Syndrome in Cancer Patients

  2018cites this paper
• Isolation of Breast cancer CTCs with multitargeted buoyant immunomicrobubbles.

  2018cites this paper
• Exosome-Based Cell-Cell Communication in the Tumor Microenvironment

  2018cites this paper
• Contact System Activation and Cancer: New Insights in the Pathophysiology of Cancer-Associated Thrombosis

  2018cites this paper
• Effects of platelets on cancer progression.

  2018cites this paper
• Oxidant stress as a major determinant of platelet activation in invasive breast cancer

  2017cites this paper
• Characterization of Extracellular Vesicles by Flow Cytometry.

  2017cites this paper
• Tumor-Derived Exosomes Induce the Formation of Neutrophil Extracellular Traps: Implications For The Establishment of Cancer-Associated Thrombosis

  2017cites this paper
• Cancer antigen 15-3, platelet distribution width, and fibrinogen in combination to distinguish breast cancer from benign breast disease in non-conclusive mammography patients

  2017cites this paper
• Breast-cancer extracellular vesicles induce platelet activation and aggregation by tissue factor-independent and -dependent mechanisms.

  2017cites this paper
• Complications and thromboembolic events associated with tamoxifen therapy in patients with breast cancer undergoing microvascular breast reconstruction: a systematic review and meta-analysis

  2017cites this paper
• Transfusion-related immunomodulation and cancer.

  2017cites this paper
• From platelet dust to gold dust: physiological importance and detection of platelet microvesicles

  2017cites this paper
• Platelet microvesicles in health and disease

  2017cites this paper
• Platelet extracellular vesicles as biomarkers for arterial thrombosis

  2017cites this paper
• Analyse quantitative et qualitative sur puce de vésicules extracellulaires en milieux complexes au sein d'une plateforme nanobioanalytique

  2017cites this paper
• Mechanisms and risk factors of thrombosis in cancer.

  2017cites this paper
• The influence of cancer on platelet behaviour Thrombocytosis in cancer

  2017cites this paper
• Levels of activated platelet-derived microvesicles in patients with soft tissue sarcoma correlate with an increased risk of venous thromboembolism

  2017cites this paper
• Microparticle analysis in disorders of hemostasis and thrombosis

  2016cites this paper
• Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients

  2016cites this paper
• Cancer Patient–Derived Circulating Microparticles Enhance Lung Metastasis in a Rat Model: Dual-Source CT, Cellular, and Molecular Studies

  2016cites this paper
• Contributions of phosphatidylserine-positive platelets and leukocytes and microparticles to hypercoagulable state in gastric cancer patients

  2016cites this paper
• Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression

  2016cites this paper
• Extracellular membrane vesicles in blood products-biology and clinical relevance

  2016cites this paper
• Impact of collection, isolation and storage methodology of circulating microvesicles on flow cytometric analysis

  2015cites this paper
• Microparticles as Potential Biomarkers of Cardiovascular Disease

  2015cites this paper
• Microvesicles as a potential biomarker of neoplastic diseases and their role in development and progression of neoplasm

  2015cites this paper
• Microparticles in cancer: A review of recent developments and the potential for clinical application.

  2015cites this paper
• Rapid Anticoagulation Reversal With Prothrombin Complex Concentrate Before Emergency Brain Tumor Surgery

  2015cites this paper
• Platelet microparticles and cancer: An intimate cross-talk.

  2015cites this paper
• Antigenic composition of single nano-sized extracellular blood vesicles.

  2015cites this paper
• Oat-enriched diet reduces inflammatory status assessed by circulating cell-derived microparticle concentrations in type 2 diabetes.

  2014cites this paper
• Involvement of platelet-derived microparticles in tumor progression and thrombosis.

  2014cites this paper
• Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status

  2014cites this paper
• Platelets in cancer and thrombosis

  2014cites this paper
• Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine.

  2014cites this paper
• Study of the thrombogenicity induced by the cytotoxic treatment of malignant disease

  2014cites this paper
• AVALIAÇÃO DE BIOMARCADORES INFLAMATÓRIOS MOLECULARES EM PACIENTES COM CÂNCER DE MAMA

  2014influential citation
• Differential influence of breast cancer stage , time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability

  2014cites this paper
• Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability

  2014cites this paper
• Anti-VEGF-A Affects the Angiogenic Properties of Tumor-Derived Microparticles

  2014cites this paper
• The LPS‐induced increase in circulating microparticles is not affected by vitamin C in humans

  2013cites this paper
• Microvesicles as Potential Ovarian Cancer Biomarkers

  2013cites this paper
• Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistance.

  2013cites this paper
• Tumor Growth and Metastasis

  2013cites this paper
• Circulating Endothelial Cells and Microparticles as Prognostic Markers in Advanced Non-Small Cell Lung Cancer

  2012cites this paper
• Epidemiology, risk and outcomes of venous thromboembolism in cancer

  2012cites this paper
• Methodology for isolation, identification and characterization of microvesicles in peripheral blood.

  2012cites this paper
• Apoptosis in esophagus and pancreas carcinoma cells induced by circulating microparticles is related to phosphatidyl serine and microparticle-associated caspases

  2012cites this paper
• Circulating microparticles in systemic Lupus Erythematosus.

  2012cites this paper
• Platelet-Derived Microparticles in Patients with Colorectal Cancer

  2012cites this paper
• Breast Cancer as an Acquired Thrombophilic State

  2012influential citation
• Coagulation activation and microparticle-associated coagulant activity in cancer patients

  2012cites this paper
• Platelet-Derived Microvesicles: Multitalented Participants in Intercellular Communication

  2012cites this paper
• Circulating microparticles in patients with benign and malignant ovarian tumors.

  2012cites this paper
• Surveillance of megakaryocytic function by measurement of CD61‐exposing microparticles in allogeneic hematopoietic stem cell recipients

  2011cites this paper
• Microparticles for Diagnosis of Graft-Versus-Host Disease After Allogeneic Stem Transplantation

  2011cites this paper
• Clearance of platelet microparticles in vivo

  2011cites this paper
• Increased plasma level of asymmetric dimethylarginine in hypertensive rats facilitates platelet aggregation: role of plasma tissue factor.

  2011cites this paper
• Apheresis platelet concentrates contain platelet‐derived and endothelial cell‐derived microparticles

  2011cites this paper
• Novel test for microparticles in platelet‐rich plasma and platelet concentrates using dynamic light scattering

  2011cites this paper
• Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters.

  2011cites this paper
• Neue diagnostische Marker bei Mammakarzinompatientinnen

  2011influential citation
• Prognostic value of plasma d-dimer levels in patients with glioblastoma multiforme – Results from a pilot study

  2011cites this paper
• Arterial and Venous Thrombosis in Cancer Patients

  2011cites this paper
• Forekomst av kreft og VTE hos pasienter med hjerteinfarkt uten koronare stenoser

  2011cites this paper
• Thrombosis in cancer

  2011cites this paper
• Contribution of platelets to tumour metastasis

  2011cites this paper
• Risque thromboembolique et prise en charge du cancer du sein

  2011cites this paper
• Circulating procoagulant microparticles in cancer patients

  2011cites this paper
• Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma

  2010cites this paper
• CEA-, Her2/neu-, BCRP- and Hsp27-positive microparticles in breast cancer patients.

  2010cites this paper